Suppr超能文献

腹腔镜胆囊癌根治术联合淋巴结清扫术治疗胆囊癌

Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma.

作者信息

Shirobe Takashi, Maruyama Shotaro

机构信息

Department of Surgery, Chiba Tokushukai Hospital, 2-11-1 Takanedai, Funabashi, Chiba, 274-8503, Japan,

出版信息

Surg Endosc. 2015 Aug;29(8):2244-50. doi: 10.1007/s00464-014-3932-9. Epub 2014 Oct 11.

Abstract

BACKGROUND

Laparoscopic surgery has been widely employed in the field of digestive surgery, since the minimally invasive procedure provides a significant benefit to patients. However, laparoscopic curative surgery for gallbladder cancer has been rarely described. The aim of this study was to evaluate the effectiveness and validity of laparoscopic radical cholecystectomy with lymph node dissection (Lap-RC) to treat with T1b/T2 gallbladder carcinoma.

METHODS

A total of 11 patients underwent Lap-RC for gallbladder carcinoma from November 2001 until June 2013. While 4 patients were preoperatively diagnosed with T1b/T2 gallbladder carcinoma, 7 patients were diagnosed with incidental T1b/T2 gallbladder carcinoma by postoperative pathological examination after laparoscopic cholecystectomy. Common bile duct resection and biliary tract reconstruction were performed in 2 cases. End points in this clinical study were tumor recurrence and survival of patients.

RESULTS

Mean operative time was 196 min, and average hospital stay after surgery was 6.4 days, excluding 2 cases with biliary tract reconstruction. One patient died of recurrence of cancer 89 months after surgery, and another patient died of other reason with local recurrence 39 months after the operation. The other 9 patients were all alive without recurrence at this writing. The 5-year survival rate was 100 % for T1b patients and 83.3 % for T2. These results indicate that almost equivalent outcomes compared with open surgery in terms of curability were achieved.

CONCLUSIONS

We conclude that pure laparoscopic radical cholecystectomy with lymph node dissection is safe and beneficial for the patients with T1b/T2 gallbladder carcinoma.

摘要

背景

腹腔镜手术已在消化外科领域广泛应用,因为这种微创手术给患者带来显著益处。然而,关于腹腔镜胆囊癌根治性手术的报道很少。本研究的目的是评估腹腔镜根治性胆囊切除术联合淋巴结清扫术(Lap-RC)治疗T1b/T2期胆囊癌的有效性和安全性。

方法

2001年11月至2013年6月,共有11例患者接受了Lap-RC治疗胆囊癌。其中4例患者术前诊断为T1b/T2期胆囊癌,7例患者在腹腔镜胆囊切除术后经病理检查诊断为意外T1b/T2期胆囊癌。2例患者进行了胆总管切除和胆道重建。本临床研究的终点是患者的肿瘤复发和生存情况。

结果

平均手术时间为196分钟,排除2例胆道重建患者后,术后平均住院时间为6.4天。1例患者术后89个月死于癌症复发,另1例患者术后39个月死于其他原因伴局部复发。截至撰写本文时,其他9例患者均存活且无复发。T1b期患者的5年生存率为100%,T2期为83.3%。这些结果表明,在可治愈性方面与开放手术取得了几乎相当的结果。

结论

我们得出结论,单纯腹腔镜根治性胆囊切除术联合淋巴结清扫术对T1b/T2期胆囊癌患者是安全且有益的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验